SOURCE: Axxess Pharma Inc
TORONTO, ON--(Marketwired - Sep 16, 2013) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to appoint Mr. Robert Tallack as VP of OTC & Online Sales and Marketing.
Robert Tallack brings a successful track record in online sales and entry into big box retailers along with his knowledge and background in the sports nutrition industry. Mr. Tallack has also been pivotal in developing new formulations for successful health care products.
Daniel Bagi, M.D., President and CEO of Axxess Pharma Inc. stated: "We are delighted to have Robert on board, his expertise in OTC products, supplements and online sales will be key for AXXESS to attain its goal of a rapid ramp up in sales. In addition, Robert brings a wealth of knowledge in proprietary formulations and patents to AXXESS."
Robert Tallack holds a Health Science B.A. from Queens University and a college degree in Fitness and Nutrition.
Robert has a unique background including a career as a professional fighter, with titles including 3-time World Karate Champion, 9-time Canadian National Martial Arts Champion and world record holder.
Robert was a pioneer of Mixed Martial Arts (MMA, commonly known as 'UFC') in Canada, starting his career in 1994 before turning Pro in 1999.
Aside from Robert's Martial Arts and fitness background he is an accomplished entrepreneur, having previously built three companies in the health industry.
Robert is a member of the prestigious 'Fitness Industry Council' advisory board member, as well as a leading member of Canada's premier Martial Arts association, 'DNBK'.
For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, -- to optimal health management through improved nutritional supplements.
Safe Harbor Statement:
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.